The Beauty Health Company
General ticker "SKIN" information:
- Sector: Consumer Staples
- Industry: Personal Care Products
- Capitalization: $202.5M (TTM average)
The Beauty Health Company follows the US Stock Market performance with the rate: 39.4%.
Estimated limits based on current volatility of 3.9%: low 1.47$, high 1.59$
Factors to consider:
- Total employees count: 769 (-12.7%) as of 2024
- North and South America accounted for 64.9% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Market competition, Reputation and brand risks, Supply chain disruptions, Strategic risks and growth management, Geopolitical risks
- Price in estimated range
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [1.04$, 2.71$]
- 2025-12-31 to 2026-12-31 estimated range: [1.39$, 3.34$]
Financial Metrics affecting the SKIN estimates:
- Positive: with PPE of -3.5 at the end of fiscal year the price was low
- Negative: negative Operating income
- Positive: 0 < Industry earnings per price (median), % of 0.38
- Positive: 6.82 < Operating cash flow per share per price, % of 8.62
- Positive: -8.75 < Industry operating profit margin (median), % of 1.21
- Positive: -4.48 < Investing cash flow per share per price, % of -3.63
- Positive: Inventory ratio change, % of -1.95 <= -0.75
Short-term SKIN quotes
Long-term SKIN plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $365.88MM | $397.99MM | $334.29MM |
| Operating Expenses | $390.16MM | $528.91MM | $402.07MM |
| Operating Income | $-24.28MM | $-130.92MM | $-67.77MM |
| Non-Operating Income | $69.31MM | $29.03MM | $38.22MM |
| Interest Expense | $13.39MM | $13.65MM | $10.41MM |
| R&D Expense | $8.44MM | $10.10MM | $6.30MM |
| Income(Loss) | $45.03MM | $-101.89MM | $-29.55MM |
| Taxes | $0.65MM | $-1.77MM | $-0.45MM |
| Profit(Loss)* | $44.22MM | $-100.12MM | $-29.10MM |
| Stockholders Equity | $171.48MM | $59.39MM | $51.80MM |
| Inventory | $109.66MM | $91.32MM | $69.11MM |
| Assets | $1,008.91MM | $929.11MM | $685.68MM |
| Operating Cash Flow | $-106.60MM | $21.75MM | $16.13MM |
| Capital expenditure | $17.39MM | $13.05MM | $6.79MM |
| Investing Cash Flow | $-18.87MM | $-31.51MM | $-6.79MM |
| Financing Cash Flow | $-205.24MM | $-37.45MM | $-158.34MM |
| Earnings Per Share** | $0.30 | $-0.76 | $-0.23 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.